List of Studies ( Metabolite:SM 18:1;O2/17:0)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Units(range) |
|---|---|---|---|---|---|---|---|
| ST003077 | AN005035 | Data-dependent and -independent acquisition lipidomics analysis reveals the tissue-dependent effect of metformin on lipid metabolism (Adipose tissue measurements) | Adipose tissue | Mouse | North Carolina State University | arbitrary unit | |
| ST003077 | AN005035 | Data-dependent and -independent acquisition lipidomics analysis reveals the tissue-dependent effect of metformin on lipid metabolism (Adipose tissue measurements) | Blood | Mouse | North Carolina State University | arbitrary unit | |
| ST003077 | AN005035 | Data-dependent and -independent acquisition lipidomics analysis reveals the tissue-dependent effect of metformin on lipid metabolism (Adipose tissue measurements) | Heart | Mouse | North Carolina State University | arbitrary unit | |
| ST003077 | AN005035 | Data-dependent and -independent acquisition lipidomics analysis reveals the tissue-dependent effect of metformin on lipid metabolism (Adipose tissue measurements) | Intestine | Mouse | North Carolina State University | arbitrary unit | |
| ST003077 | AN005035 | Data-dependent and -independent acquisition lipidomics analysis reveals the tissue-dependent effect of metformin on lipid metabolism (Adipose tissue measurements) | Kidney | Mouse | North Carolina State University | arbitrary unit | |
| ST003077 | AN005035 | Data-dependent and -independent acquisition lipidomics analysis reveals the tissue-dependent effect of metformin on lipid metabolism (Adipose tissue measurements) | Liver | Mouse | North Carolina State University | arbitrary unit | |
| ST003077 | AN005035 | Data-dependent and -independent acquisition lipidomics analysis reveals the tissue-dependent effect of metformin on lipid metabolism (Adipose tissue measurements) | Muscle | Mouse | North Carolina State University | arbitrary unit | |
| ST002150 | AN003520 | Sphingomyelin depletion inhibits CXCR4 dynamics and CXCL12-mediated directed cell migration in human T cells | HEK cells | Human | Universidad CEU San Pablo | AREA | |
| ST002911 | AN004780 | LiLA: Lipid Lung-based ATLAS built Through a Comprehensive Workflow Designed for an Accurate Lipid Annotation | Lung | Mouse | Tuberculosis | Universidad CEU San Pablo | AREA |
| ST002911 | AN004781 | LiLA: Lipid Lung-based ATLAS built Through a Comprehensive Workflow Designed for an Accurate Lipid Annotation | Lung | Mouse | Tuberculosis | Universidad CEU San Pablo | AREA |
| ST001639 | AN002682 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort | Blood | Human | COPD | National Jewish Health | AU |
| ST003103 | AN005077 | Reinforcing the Evidence of Mitochondrial Dysfunction in Long COVID Patients using a Multiplatform Mass Spectrometry-based Metabolomics Approach | Blood | Human | COVID-19 | Universidad CEU San Pablo | Corrected areas |
| ST003514 | AN005769 | Highly reliable LC-MS lipidomics database for efficient human plasma profiling based on NIST SRM 1950 | Blood | Human | Universidad CEU San Pablo | Corrected areas | |
| ST001403 | AN002345 | Ontogeny related changes in the pediatric liver metabolome (part-II) | Liver | Human | Moffitt Cancer Center | estimated abundances | |
| ST002555 | AN004207 | Ethnicity-Specific Differences in Ovarian Cancer Metabolic Signatures | Cultured cells | Human | Cancer | University of Oklahoma Health Sciences Center | Fold change over standard |
| ST002155 | AN003530 | Longitudinal metabolomic stool dynamics in primary C. difficile infections | Feces | Human | Bacterial infection | Brigham Women's Hospital | intensity |
| ST002149 | AN003519 | In vivo commensal control of Clostridioides difficile virulence | Cecum | Mouse | Brigham and Women’s Hospital | Intensity | |
| ST001775 | AN002882 | Plasma metabolomics of diverse mouse strains infected with Plasmodium chabaudi | Blood | Mouse | Malaria | Stanford University | ion counts |
| ST003222 | AN005283 | A small molecule macrophage migration inhibitory factor agonist ameliorates age-related myocardial intolerance to ischemia-reperfusion insults via metabolic regulation - Part 1 | Heart | Mouse | Ischemia | University of Mississippi Medical Center | lipid content in the sample (nmol/g) |
| ST002956 | AN004853 | An application of automated LLE extraction in determine the age and HFD effects in adult mice in metabolomic, lipidomic, and proteomic | Blood | Mouse | Calico Life Sciences | Log2(Top Peak Area) | |
| ST000983 | AN001609 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (Part I) | Blood | Human | University of California, Davis | nanograms (absolute) | |
| ST000984 | AN001610 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part II) | Blood | Human | University of California, Davis | nanograms (absolute) | |
| ST000985 | AN001611 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part III) | Blood | Human | University of California, Davis | nanograms (absolute) | |
| ST000986 | AN001612 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part IV) | Blood | Human | University of California, Davis | nanograms (absolute) | |
| ST000987 | AN001613 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part V) | Blood | Human | University of California, Davis | nanograms (absolute) | |
| ST000988 | AN001614 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VI) | Blood | Human | University of California, Davis | nanograms (absolute) | |
| ST000989 | AN001615 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VII) | Blood | Human | University of California, Davis | nanograms (absolute) | |
| ST000990 | AN001616 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part VIII) | Blood | Human | University of California, Davis | nanograms (absolute) | |
| ST000991 | AN001617 | Validating Quantitative Untargeted Lipidomics Across Nine Liquid Chromatography−High-Resolution Mass Spectrometry Platforms (part IX) | Blood | Human | University of California, Davis | nanograms (absolute) | |
| ST002322 | AN003789 | Metabolomics study comparing SCAP KO and WT B cells | Cultured cells | Mouse | Indiana University School of Medicine | Normalized AUC | |
| ST002304 | AN003765 | White-nose syndrome disrupts the splenic lipidome of little brown bats (Myotis lucifugus) at early disease stages | Spleen | Little brown bat | White-nose syndrome | Georgetown University | peak area |
| ST003044 | AN004994 | A High-Fat Eucaloric Diet Induces Reprometabolic Syndrome of Obesity in Normal Weight Women - lipidomics | Blood | Human | Obesity | University of Colorado Denver | peak area |
| ST000310 | AN000490 | TC and B6 untreated plasma in lupus-prone mice lipidomics (part-II) | Blood | Mouse | Lupus | University of Florida | Peak area |
| ST000612 | AN000937 | Sphingolipid Analysis of Human Aqueous Humor in Glaucomatous and Control eyes | Eye tissue | Human | Eye disease | University of Miami | Peak area |
| ST000613 | AN000938 | Human TM Sphingolipid Analysis (part II) | Eye tissue | Human | Eye disease | University of Miami | Peak area |
| ST000620 | AN000952 | Sphingolipid Analysis of hyper and normotensive DBA2J mice aqueous humor and trabecular meshwork | Mouse | Eye disease | University of Miami | Peak area | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Brain | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Liver | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001063 | AN001739 | Lipidomics analysis for aged mice organs | Muscle | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Brain | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Liver | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001065 | AN001742 | Lipidomics analysis for aged mice brain cortex (part-II) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Brain | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Liver | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001066 | AN001744 | Lipidomics analysis for aged mice liver (part-III) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Brain | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Liver | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001067 | AN001746 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | Peak area | |
| ST001157 | AN001915 | The gut microbiota plays a central role to modulate the plasma metabolome in response to chronic Angiotensin II infusion (part-I) | Blood | Mouse | Johns Hopkins University School of Medicine | Peak area | |
| ST001212 | AN002044 | Fish-oil supplementation in pregnancy, child metabolomics and asthma risk | Blood | Human | Copenhagen Prospective Studies on Asthma in Childhood, Herlev and Gentofte Hospital, University of Copenhagen | Peak area | |
| ST001411 | AN002361 | Plasma metabolites of lipid metabolism associate with diabetic polyneuropathy in a cohort with screen-tested type 2 diabetes: ADDITION-Denmark | Blood | Human | Obesity | University of Michigan | Peak area |
| ST002787 | AN004534 | Metabolomic analysis of gut metabolites in colorectal cancer patients: correlation with disease development and outcome | Feces | Human | Cancer | Wuhan University of Science and Technology | Peak Area |
| ST000310 | AN000492 | TC and B6 untreated plasma in lupus-prone mice lipidomics (part-II) | Blood | Mouse | Lupus | University of Florida | Peak height |
| ST000342 | AN000554 | Renal metabolic pathways indicating ischemic or inflammatory changes | Kidney | Human | Acute kidney injury | University of California, Davis | Peak height |
| ST000346 | AN000562 | Metabolites detected from human bronchoalveolar lavage | Lung | Human | University of California, Davis | Peak height | |
| ST000403 | AN000642 | Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes | Cells | Human | Monash Institute of Pharmaceutical Sciences, Monash University | Peak height | |
| ST000539 | AN000818 | Metabolomics-based elucidation of active metabolic pathways in erythrocytes and HSC-derived reticulocytes (part II) | Cells | Human | Monash Institute of Pharmaceutical Sciences, Monash University | Peak height | |
| ST000608 | AN000929 | Comparing identified and statistically significant lipids and polar metabolites in 15-year old serum and dried blood spot samples for longitudinal studies | Blood | Human | Pacific Northwest National Laboratory | Peak height | |
| ST001102 | AN001792 | Physiological and metabolic response of crab megalopae and juveniles to ocean acidification (part-II) | Whole animals | Crab | NOAA NWFSC, | Peak height | |
| ST001154 | AN001943 | A comprehensive plasma metabolomics dataset for a cohort of mouse knockouts within the International Mouse Phenotyping Consortium | Blood | Mouse | University of California | Peak height normalized with creatinine | |
| ST001311 | AN002182 | Lipid expression in liver after early lifer exposure to an endocrine disruptor at 70 days postnatal in the liver (part-II) | Liver | Rat | Environmental exposure | Baylor College of Medicine | Peak intensity |
| ST001311 | AN002183 | Lipid expression in liver after early lifer exposure to an endocrine disruptor at 70 days postnatal in the liver (part-II) | Liver | Rat | Environmental exposure | Baylor College of Medicine | Peak intensity |
| ST001312 | AN002184 | Lipid expression in serum after early lifer exposure to an endocrine disruptor at 70 days postnatal (part-III) | Blood | Rat | Environmental exposure | Baylor College of Medicine | Peak intensity |
| ST001312 | AN002185 | Lipid expression in serum after early lifer exposure to an endocrine disruptor at 70 days postnatal (part-III) | Blood | Rat | Environmental exposure | Baylor College of Medicine | Peak intensity |
| ST001313 | AN002186 | Lipid expression in serum after early life exposure to an endocrine disruptor and a Western Diet at 240 days postnatal (part-IV) | Blood | Rat | Environmental exposure | Baylor College of Medicine | Peak intensity |
| ST001313 | AN002187 | Lipid expression in serum after early life exposure to an endocrine disruptor and a Western Diet at 240 days postnatal (part-IV) | Blood | Rat | Environmental exposure | Baylor College of Medicine | Peak intensity |
| ST001827 | AN002963 | The pregnancy metabolome from a multi-ethnic pregnancy cohort | Blood | Human | Icahn School of Medicine at Mount Sinai | pmoles/l | |
| ST003220 | AN005280 | Obesity, sex, and depot drive distinct lipid profiles in murine white adipose tissue | Adipose tissue | Mouse | Obesity | University of Utah | pmol/mg tissue |
| ST001405 | AN002347 | MDM2-Dependent Rewiring of Metabolomic and Lipidomic Profiles in Dedifferentiated Liposarcoma Models | Cultured cells | Human | The Ohio State University | ppm | |
| ST001983 | AN003234 | Metabolomic Fingerprinting of Human High Grade Serous Ovarian Carcinoma Cell Lines | Ovarian cancer cells | Human | Cancer | University of Oklahoma Health Sciences Center | ratio |
| ST001835 | AN002977 | Use of Integrated Metabolomics, Transcriptomics, and Signal Protein Profile to Characterize the Effector Function and Associated Metabotype of Polarized Macrophage Phenotypes | Blood | Human | Idaho Veterans Research and Education Foundation | raw area count | |
| ST000899 | AN001463 | Alterations in Lipid, Amino Acid, and Energy Metabolism Distinguish Crohn Disease from Ulcerative Colitis and Control Subjects by Serum Metabolomic Profiling | Blood | Human | Inflammatory bowel disease | Vanderbilt University Medical Center | raw area counts |
| ST001749 | AN002849 | REACH Metabolomics Study | Blood | Human | Alzheimers disease | University of Wisconsin - Madison | Raw area counts |
| ST001404 | AN002346 | Ontogeny related changes in the pediatric liver metabolome (part-III) | Liver | Human | Moffitt Cancer Center | Relative Abundance | |
| ST002088 | AN003407 | Plasma Metabolomic signatures of COPD in a SPIROMICS cohort: A metabolomic severity score for airflow obstructions and emphysema | Blood | Human | COPD | National Jewish Health | relativeMedian |
| ST002089 | AN003411 | Plasma metabolomic signatures of COPD: A metabolomic severity score for airflow obstruction and emphysema. | Blood | Human | COPD | National Jewish Health | relativeMedian |
| ST001869 | AN003031 | WNK463 Inhibition on Right Ventricular metabolomics | Heart | Rat | Hypertension | University of Minnesota | relative value |
| ST001870 | AN003032 | Effects of GP130 Antagonism on Right Ventricular Metabolism in Monocrotaline Rats | Heart | Rat | University of Minnesota | relative value | |
| ST002017 | AN003287 | Multi-omic analysis of the microbiome and metabolome in healthy subjects (blood) | Blood | Human | Vanderbilt University Medical Center | scaled imputed | |
| ST002018 | AN003288 | Multi-omic analysis of the microbiome and metabolome in healthy subjects (feces) | Feces | Human | Vanderbilt University Medical Center | scaled imputed | |
| ST002019 | AN003289 | TIPs Metabolomics (blood) | Blood | Human | Vanderbilt University Medical Center | scaled imputed | |
| ST000930 | AN001524 | Define alterations in the gut metabolome of mice infected with C. difficile | Intestine | Mouse | North Carolina State University | scaled intensity | |
| ST001253 | AN002080 | Phenotyping Mouse blood metabolites in day and night in type 2 diabetes | Blood | Mouse | Diabetes | Indiana University School of Medicine | VolNormImp Area counts |
